Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,595.07,09/21/2013,GNRL,104020798
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,218.42,09/21/2013,GNRL,104020800
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,106.84,09/04/2013,GNRL,104021946
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,104.76,10/09/2014,GNRL,158772714
244775,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,104.46,08/27/2013,GNRL,23818303
244775,GNRL,"AbbVie, Inc.",IL,100000000204,99.52,09/09/2015,GNRL,317406268
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,97.98,10/24/2013,GNRL,100338978
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,92.36,11/05/2014,GNRL,194852410
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,92.30,12/19/2013,GNRL,104019734
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,82.30,09/21/2013,GNRL,104020796
244775,GNRL,"Janssen Products, LP",PA,100000000325,81.00,12/18/2013,GNRL,17399984
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,75.23,07/16/2014,GNRL,158581670
244775,GNRL,"Janssen Scientific Affairs, LLC",NJ,100000000332,68.81,12/15/2015,GNRL,270398962
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,64.40,09/21/2013,GNRL,104020794
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,63.44,09/21/2013,GNRL,104020792
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,57.76,05/27/2015,GNRL,339859904
244775,GNRL,"UCB, Inc.",GA,100000000073,27.54,10/23/2013,GNRL,102064898
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,22.69,09/11/2013,GNRL,104009590
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,22.04,05/08/2014,GNRL,158845908
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,21.80,09/03/2013,GNRL,104004248
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,21.72,12/17/2013,GNRL,104019740
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,21.18,05/15/2014,GNRL,149663054
244775,GNRL,"Santarus, Inc",NC,100000010767,20.75,10/24/2013,GNRL,103671788
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,20.23,01/05/2015,GNRL,270349848
244775,GNRL,"Shire North American Group Inc",MA,100000061292,19.70,01/14/2015,GNRL,299155808
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,19.58,09/14/2015,GNRL,252774922
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.56,04/22/2014,GNRL,148803836
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,19.50,07/17/2014,GNRL,149669594
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,19.49,05/01/2014,GNRL,156994078
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,19.39,01/09/2015,GNRL,295222978
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,19.28,03/09/2015,GNRL,295223000
244775,GNRL,"AbbVie, Inc.",IL,100000000204,18.87,04/15/2015,GNRL,317235116
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,18.74,04/13/2015,GNRL,270349850
244775,GNRL,"UCB, Inc.",GA,100000000073,18.69,09/09/2014,GNRL,169197362
244775,GNRL,"AbbVie, Inc.",IL,100000000204,18.63,02/26/2014,GNRL,189183400
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,18.58,07/27/2015,GNRL,252773340
244775,GNRL,"AbbVie, Inc.",IL,100000000204,18.48,10/17/2013,GNRL,31116776
244775,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,18.35,04/03/2014,GNRL,192224632
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,18.31,07/16/2015,GNRL,324957866
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,18.20,11/16/2015,GNRL,252777398
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,18.19,08/04/2014,GNRL,158590968
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,18.12,03/11/2014,GNRL,148321784
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.93,09/25/2013,GNRL,31116775
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.89,10/16/2014,GNRL,189551474
244775,GNRL,"UCB, Inc.",GA,100000000073,17.88,02/10/2015,GNRL,260215244
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.85,04/28/2015,GNRL,317240712
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,17.78,03/10/2014,GNRL,156994074
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,17.77,12/04/2013,GNRL,11181145
244775,GNRL,"UCB, Inc.",GA,100000000073,17.76,11/03/2014,GNRL,170083990
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,17.61,05/05/2015,GNRL,270349860
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.59,11/18/2015,GNRL,316962666
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.58,11/28/2013,GNRL,31116772
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.48,03/13/2014,GNRL,189213694
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,17.33,06/02/2015,GNRL,270349864
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,17.25,12/16/2015,GNRL,326490354
244775,GNRL,"AbbVie, Inc.",IL,100000000204,17.10,07/24/2014,GNRL,189423656
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.03,09/24/2013,GNRL,103346560
244775,GNRL,"AbbVie, Inc.",IL,100000000204,16.93,03/23/2015,GNRL,317260000
244775,GNRL,"UCB, Inc.",GA,100000000073,16.80,05/06/2014,GNRL,170083988
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.77,04/01/2015,GNRL,270349855
244775,GNRL,"Shire North American Group Inc",MA,100000061292,16.76,07/01/2015,GNRL,300649806
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.75,10/29/2014,GNRL,156994072
244775,GNRL,"UCB, Inc.",GA,100000000073,16.70,01/13/2015,GNRL,260209458
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,16.65,01/28/2014,GNRL,158654738
244775,GNRL,"AbbVie, Inc.",IL,100000000204,16.64,10/09/2015,GNRL,317235256
244775,GNRL,"AbbVie, Inc.",IL,100000000204,16.60,10/13/2015,GNRL,317254746
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.58,02/04/2014,GNRL,156994090
244775,GNRL,"Shire North American Group Inc",MA,100000061292,16.55,08/19/2015,GNRL,300649820
244775,GNRL,"Shire North American Group Inc",MA,100000061292,16.47,06/17/2015,GNRL,300245948
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.42,07/23/2015,GNRL,270349872
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,16.37,06/16/2015,GNRL,252771954
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,16.35,03/04/2014,GNRL,149655274
244775,GNRL,"AbbVie, Inc.",IL,100000000204,16.24,01/22/2015,GNRL,317167852
244775,GNRL,"AbbVie, Inc.",IL,100000000204,16.18,09/10/2015,GNRL,317182038
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.17,08/20/2014,GNRL,156994082
244775,GNRL,"UCB, Inc.",GA,100000000073,16.07,03/24/2015,GNRL,260205778
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,16.06,02/05/2015,GNRL,270349886
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.02,08/18/2014,GNRL,187471686
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,16.01,09/02/2014,GNRL,158707708
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.96,07/21/2014,GNRL,158559698
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.87,02/17/2014,GNRL,148302042
244775,GNRL,"Shire North American Group Inc",MA,100000061292,15.81,11/05/2014,GNRL,136385884
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.69,03/10/2015,GNRL,295223004
244775,GNRL,"AbbVie, Inc.",IL,100000000204,15.62,12/08/2015,GNRL,317010710
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,15.60,08/25/2014,GNRL,191639516
244775,GNRL,"AbbVie, Inc.",IL,100000000204,15.56,09/25/2014,GNRL,189519916
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,15.52,02/17/2015,GNRL,252767402
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.46,11/19/2014,GNRL,158860824
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,15.41,04/07/2014,GNRL,156994076
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,15.39,02/03/2014,GNRL,156994062
244775,GNRL,"Shire North American Group Inc",MA,100000061292,15.31,07/20/2015,GNRL,300649812
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,15.28,10/22/2015,GNRL,270349837
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,15.21,10/15/2015,GNRL,252776092
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,15.19,09/04/2014,GNRL,149674446
244775,GNRL,"AbbVie, Inc.",IL,100000000204,15.13,11/12/2013,GNRL,31116774
244775,GNRL,"Shire US Holdings",PA,100000000241,15.10,10/08/2013,GNRL,6365695
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.10,07/16/2014,GNRL,158574377
244775,GNRL,"AbbVie, Inc.",IL,100000000204,15.09,08/21/2014,GNRL,189463942
244775,GNRL,"AbbVie, Inc.",IL,100000000204,15.09,06/26/2014,GNRL,189386758
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.03,01/15/2014,GNRL,150875362
244775,GNRL,"UCB, Inc.",GA,100000000073,15.01,10/08/2014,GNRL,169197372
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.87,09/04/2013,GNRL,102080310
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,14.85,04/30/2015,GNRL,295223022
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,14.82,08/28/2014,GNRL,158700896
244775,GNRL,"Shire North American Group Inc",MA,100000061292,14.78,02/18/2015,GNRL,299155814
244775,GNRL,"AbbVie, Inc.",IL,100000000204,14.75,08/07/2014,GNRL,189442196
244775,GNRL,"UCB, Inc.",GA,100000000073,14.69,07/08/2014,GNRL,169197344
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.67,08/14/2013,GNRL,23870432
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.63,09/01/2015,GNRL,337334434
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.62,02/26/2015,GNRL,339474868
244775,GNRL,"AbbVie, Inc.",IL,100000000204,14.59,08/12/2015,GNRL,317392620
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.53,06/19/2014,GNRL,149666934
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.49,11/12/2015,GNRL,270349830
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.43,12/15/2015,GNRL,252778464
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.38,09/15/2014,GNRL,194852400
244775,GNRL,"UCB, Inc.",GA,100000000073,14.38,08/25/2015,GNRL,260195868
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.34,08/05/2014,GNRL,149671380
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.27,12/08/2014,GNRL,149683304
244775,GNRL,"AbbVie, Inc.",IL,100000000204,14.21,05/22/2014,GNRL,189335804
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.16,12/23/2013,GNRL,23870444
244775,GNRL,"AbbVie, Inc.",IL,100000000204,14.16,03/27/2014,GNRL,189239774
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,14.10,09/22/2014,GNRL,158873056
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,14.01,10/13/2014,GNRL,149677970
244775,GNRL,"Shire North American Group Inc",MA,100000061292,14.00,04/08/2015,GNRL,300245930
244775,GNRL,"UCB, Inc.",GA,100000000073,13.99,04/02/2014,GNRL,170083986
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.99,01/01/2014,GNRL,189107344
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.99,04/03/2015,GNRL,295223010
244775,GNRL,"UCB, Inc.",GA,100000000073,13.97,10/20/2015,GNRL,260193348
244775,GNRL,"Gilead Sciences Inc",CA,100000000108,13.87,10/29/2014,GNRL,167368120
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,13.83,11/17/2014,GNRL,149681384
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.79,09/29/2014,GNRL,189523744
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.76,07/29/2015,GNRL,317234456
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,13.73,04/20/2015,GNRL,324941678
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,13.71,09/10/2013,GNRL,23870438
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,13.71,09/17/2014,GNRL,156994084
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,13.71,08/17/2015,GNRL,252774000
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.69,06/08/2015,GNRL,339420294
244775,GNRL,"Shire North American Group Inc",MA,100000061292,13.66,05/13/2015,GNRL,300245940
244775,GNRL,"UCB, Inc.",GA,100000000073,13.65,04/20/2015,GNRL,260191424
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.64,01/23/2014,GNRL,189137714
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.55,01/26/2015,GNRL,308632665
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.53,11/06/2013,GNRL,100338976
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.51,07/13/2015,GNRL,337267750
244775,GNRL,"Cook Incorporated",IN,100000010458,13.48,07/03/2014,GNRL,211347936
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.48,11/03/2015,GNRL,317279786
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.46,12/18/2014,GNRL,158881148
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.46,01/08/2015,GNRL,295222974
244775,GNRL,"Shire North American Group Inc",MA,100000061292,13.45,02/19/2014,GNRL,136385856
244775,GNRL,"AbbVie, Inc.",IL,100000000204,13.44,02/24/2015,GNRL,308902780
244775,GNRL,"UCB, Inc.",GA,100000000073,13.39,11/17/2015,GNRL,260189944
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.35,11/07/2013,GNRL,100911678
244775,GNRL,"Shire North American Group Inc",MA,100000061292,13.33,09/03/2014,GNRL,136385878
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.33,06/08/2015,GNRL,339398910
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.31,04/15/2014,GNRL,194852368
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,13.18,12/10/2015,GNRL,270349840
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,13.17,09/24/2015,GNRL,270349882
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.09,12/04/2014,GNRL,158774420
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,13.09,02/27/2014,GNRL,191639512
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.09,01/06/2015,GNRL,295222966
244775,GNRL,"UCB, Inc.",GA,100000000073,13.04,09/25/2013,GNRL,102064896
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.90,08/27/2015,GNRL,316964186
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.87,12/11/2014,GNRL,146649812
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.87,01/07/2015,GNRL,270349822
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.85,06/23/2014,GNRL,189380184
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.84,05/29/2014,GNRL,189344074
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.78,07/09/2015,GNRL,270349868
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,12.74,01/12/2015,GNRL,252766014
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.67,10/22/2013,GNRL,100883260
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.64,11/30/2015,GNRL,270349833
244775,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,12.60,12/02/2014,GNRL,191639520
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.59,10/27/2014,GNRL,189567514
244775,GNRL,"Shire North American Group Inc",MA,100000061292,12.59,12/08/2015,GNRL,301051998
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.53,07/22/2015,GNRL,317285977
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,12.53,06/11/2015,GNRL,326473060
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.48,12/10/2013,GNRL,31116773
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.48,03/25/2014,GNRL,156994092
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,12.42,04/14/2015,GNRL,252769456
244775,GNRL,"AbbVie, Inc.",IL,100000000204,12.41,01/27/2015,GNRL,309347036
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.36,06/03/2014,GNRL,158611054
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.34,01/14/2015,GNRL,339341284
244775,GNRL,"UCB, Inc.",GA,100000000073,12.33,07/28/2015,GNRL,260183744
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.31,07/31/2014,GNRL,156994080
244775,GNRL,"Shire North American Group Inc",MA,100000061292,12.31,01/08/2014,GNRL,136385854
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.29,05/05/2014,GNRL,158644464
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.22,12/17/2014,GNRL,156994064
244775,GNRL,"Shire North American Group Inc",MA,100000061292,12.16,10/01/2014,GNRL,136385880
244775,GNRL,"UCB, Inc.",GA,100000000073,12.15,08/13/2014,GNRL,170083992
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,12.15,03/25/2015,GNRL,252768738
244775,GNRL,"Shire North American Group Inc",MA,100000061292,12.00,12/09/2015,GNRL,301052007
244775,GNRL,"AbbVie, Inc.",IL,100000000204,11.91,04/14/2014,GNRL,189269950
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.87,01/21/2014,GNRL,146649808
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.76,04/08/2014,GNRL,158623376
244775,GNRL,"AbbVie, Inc.",IL,100000000204,11.76,07/09/2014,GNRL,189402288
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.75,04/21/2014,GNRL,158607178
244775,GNRL,"UCB, Inc.",GA,100000000073,11.75,12/14/2015,GNRL,260180784
244775,GNRL,"Shire North American Group Inc",MA,100000061292,11.72,07/10/2014,GNRL,136385874
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.60,02/05/2015,GNRL,295222996
244775,GNRL,"UCB, Inc.",GA,100000000073,11.46,05/19/2015,GNRL,260178340
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.45,01/23/2015,GNRL,295222982
244775,GNRL,"Shire North American Group Inc",MA,100000061292,11.44,03/14/2014,GNRL,136385858
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,11.40,08/20/2015,GNRL,270349876
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.38,08/13/2013,GNRL,104000482
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.37,11/04/2014,GNRL,158573319
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.33,11/29/2013,GNRL,104009912
244775,GNRL,"AbbVie, Inc.",IL,100000000204,11.33,02/25/2015,GNRL,309118456
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.32,05/07/2014,GNRL,148240086
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.30,07/21/2015,GNRL,339241204
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,11.28,05/12/2015,GNRL,252770562
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.22,04/02/2015,GNRL,337087694
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.16,09/17/2013,GNRL,100338974
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,11.13,04/22/2015,GNRL,326471744
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.13,04/09/2015,GNRL,337094138
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,11.12,01/29/2015,GNRL,295222986
244775,GNRL,"Shire North American Group Inc",MA,100000061292,11.11,12/03/2014,GNRL,136385892
244775,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,11.09,11/18/2014,GNRL,192224644
244775,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,11.05,10/22/2014,GNRL,192224638
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,11.00,10/23/2014,GNRL,219499912
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,10.95,07/02/2014,GNRL,219493270
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.88,10/28/2015,GNRL,337377288
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.85,08/10/2015,GNRL,339206439
244775,GNRL,"Shire North American Group Inc",MA,100000061292,10.83,04/16/2014,GNRL,136385862
244775,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.79,11/13/2013,GNRL,100338972
244775,GNRL,"Covidien Sales LLC",MA,100000000098,10.70,08/27/2014,GNRL,221971300
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,10.69,08/04/2015,GNRL,270349878
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,10.64,10/27/2015,GNRL,326482606
244775,GNRL,"Shire North American Group Inc",MA,100000061292,10.63,05/14/2014,GNRL,136385866
244775,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,10.55,11/26/2013,GNRL,21662309
244775,GNRL,"AbbVie, Inc.",IL,100000000204,10.52,06/05/2014,GNRL,189353834
244775,GNRL,"UCB, Inc.",GA,100000000073,10.50,02/11/2014,GNRL,170899290
244775,GNRL,"AbbVie, Inc.",IL,100000000204,10.47,12/17/2015,GNRL,317063716
244775,GNRL,"Prometheus Laboratories Inc.",CA,100000010425,10.43,09/08/2014,GNRL,219490370
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.40,07/01/2014,GNRL,148282882
244775,GNRL,"Shire North American Group Inc",MA,100000061292,10.40,09/30/2015,GNRL,300649826
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.39,12/18/2014,GNRL,150942800
244775,GNRL,"Shire North American Group Inc",MA,100000061292,10.39,06/12/2014,GNRL,136385870
244775,GNRL,"Genentech USA, Inc.",CA,100000000226,10.30,11/21/2013,GNRL,29796257
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.20,12/07/2015,GNRL,339149422
244775,GNRL,"AbbVie, Inc.",IL,100000000204,10.19,01/30/2014,GNRL,189149028
244775,GNRL,"UCB, Inc.",GA,100000000073,10.19,07/01/2015,GNRL,260167584
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,10.17,06/30/2014,GNRL,158726374
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,10.15,02/11/2015,GNRL,270349826
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,10.06,01/07/2014,GNRL,156994086
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.95,11/24/2014,GNRL,194852406
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.91,10/20/2014,GNRL,194852402
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,9.88,10/28/2014,GNRL,158906636
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.84,02/23/2015,GNRL,337023032
244775,GNRL,"Given Imaging, Inc.",CT,100000000348,9.45,09/04/2015,GNRL,325030006
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.26,08/06/2014,GNRL,194852386
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.14,06/17/2014,GNRL,194852376
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,8.97,02/09/2015,GNRL,339106872
244775,GNRL,"Given Imaging, Inc.",CT,100000000348,8.89,09/15/2015,GNRL,325030000
244775,GNRL,"Given Imaging, Inc.",CT,100000000348,8.78,09/28/2015,GNRL,325030010
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.54,02/23/2014,GNRL,194852388
244775,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,8.08,04/10/2014,GNRL,149659308
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.01,06/16/2014,GNRL,194852396
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,7.81,03/04/2015,GNRL,270349888
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,7.78,12/03/2015,GNRL,270349844
244775,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,7.59,11/18/2014,GNRL,150133470
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.14,12/02/2015,GNRL,339055532
244775,GNRL,"AbbVie, Inc.",IL,100000000204,6.49,09/21/2015,GNRL,317128864
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,6.41,09/06/2013,GNRL,23870434
244775,GNRL,"Shire North American Group Inc",MA,100000061292,6.40,11/05/2014,GNRL,136385888
244775,GNRL,"Shire North American Group Inc",MA,100000061292,6.34,06/12/2014,GNRL,136385868
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,6.26,10/30/2014,GNRL,156994066
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,6.23,06/09/2014,GNRL,156994068
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,4.76,10/16/2013,GNRL,103346556
244775,GNRL,"Shire North American Group Inc",MA,100000061292,4.75,09/30/2015,GNRL,302211602
244775,GNRL,"Shire North American Group Inc",MA,100000061292,4.40,05/13/2015,GNRL,302188842
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,3.60,09/21/2013,GNRL,104022868
244775,GNRL,"Shire North American Group Inc",MA,100000061292,3.60,05/14/2014,GNRL,136385864
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,3.21,12/09/2013,GNRL,23870440
244775,GNRL,"Actavis Pharma Inc",NJ,100000010642,3.03,06/04/2015,GNRL,338944060
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,1.70,10/15/2013,GNRL,103346558
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,1.16,12/23/2013,GNRL,23870442
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.86,11/05/2014,GNRL,136385886
244775,GNRL,"AbbVie, Inc.",IL,100000000204,0.84,05/22/2014,GNRL,189335806
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.83,07/01/2015,GNRL,302196454
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,0.72,09/10/2013,GNRL,23870436
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.69,04/08/2015,GNRL,302182902
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.62,01/14/2015,GNRL,302169694
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.61,08/28/2014,GNRL,158711752
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.61,02/18/2015,GNRL,302174134
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.61,03/10/2015,GNRL,295223006
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.60,12/04/2014,GNRL,158881284
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.60,01/06/2015,GNRL,295222970
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.59,07/10/2014,GNRL,136385872
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.59,09/03/2014,GNRL,136385876
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.59,06/17/2015,GNRL,302194312
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.59,04/03/2015,GNRL,295223014
244775,GNRL,"AbbVie, Inc.",IL,100000000204,0.57,01/28/2014,GNRL,189107346
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.56,10/29/2013,GNRL,104012116
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.56,04/30/2015,GNRL,295223018
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.55,10/01/2014,GNRL,136385882
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.54,12/03/2014,GNRL,136385890
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.52,05/05/2014,GNRL,158637550
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.48,11/04/2014,GNRL,158780062
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.47,11/10/2015,GNRL,302221390
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.45,04/16/2014,GNRL,136385860
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.45,01/28/2014,GNRL,158673924
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.44,09/02/2015,GNRL,337334454
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,0.43,06/11/2014,GNRL,156994070
244775,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,0.41,02/25/2014,GNRL,194852392
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.40,09/02/2014,GNRL,158810204
244775,GNRL,"Janssen Biotech, Inc.",PA,100000000329,0.38,01/07/2014,GNRL,156994088
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.37,01/08/2014,GNRL,136385852
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.33,04/08/2014,GNRL,158796438
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.32,06/04/2014,GNRL,158790464
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.31,09/03/2013,GNRL,104000536
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.31,04/21/2014,GNRL,158868734
244775,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.27,01/29/2015,GNRL,295222990
244775,GNRL,"Shire North American Group Inc",MA,100000061292,0.21,12/09/2015,GNRL,302228084
